- Home
- BNZI vs MIRA Comparison
BNZI vs MIRA Comparison
Compare BNZI & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- MIRA
- Stock Information
- Founded
- BNZI 2016
- MIRA 2020
- Country
- BNZI United States
- MIRA United States
- Employees
- BNZI N/A
- MIRA N/A
- Industry
- BNZI
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- MIRA Health Care
- Exchange
- BNZI Nasdaq
- MIRA Nasdaq
- Market Cap
- BNZI 16.5M
- MIRA 19.5M
- IPO Year
- BNZI N/A
- MIRA 2023
- Fundamental
- Price
- BNZI $0.63
- MIRA $1.25
- Analyst Decision
- BNZI Strong Buy
- MIRA Strong Buy
- Analyst Count
- BNZI 1
- MIRA 2
- Target Price
- BNZI $24.00
- MIRA $14.00
- AVG Volume (30 Days)
- BNZI 4.1M
- MIRA 204.1K
- Earning Date
- BNZI 08-13-2025
- MIRA 08-12-2025
- Dividend Yield
- BNZI N/A
- MIRA N/A
- EPS Growth
- BNZI N/A
- MIRA N/A
- EPS
- BNZI N/A
- MIRA N/A
- Revenue
- BNZI $6,827,490.00
- MIRA N/A
- Revenue This Year
- BNZI $570.18
- MIRA N/A
- Revenue Next Year
- BNZI $34.44
- MIRA N/A
- P/E Ratio
- BNZI N/A
- MIRA N/A
- Revenue Growth
- BNZI 52.95
- MIRA N/A
- 52 Week Low
- BNZI $0.54
- MIRA $0.51
- 52 Week High
- BNZI $11.20
- MIRA $5.01
- Technical
- Relative Strength Index (RSI)
- BNZI 37.33
- MIRA 50.57
- Support Level
- BNZI $0.54
- MIRA $1.21
- Resistance Level
- BNZI $0.69
- MIRA $1.26
- Average True Range (ATR)
- BNZI 0.09
- MIRA 0.08
- MACD
- BNZI 0.01
- MIRA -0.00
- Stochastic Oscillator
- BNZI 17.62
- MIRA 41.67
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.